Drugs & Healthcare
Computing & Data Storage
Science & Research
The Zenome project is a decentralized blockchain-driven database of genomic information.
Zenome platform supports the possibility to manage your genomic data while maintaining privacy and ability to make a profit from selling access to different parts of the genome. Zenome establishes equal conditions for drug development and for the progress of scientific and medical technologies.
The principal Zenome customers of genetic information are companies interested in genetic targeting such as Google, Facebook, Unilever and pharmaceutical companies.
Zenome DNA (ZNA) is a utility token on Zenome platform.
On the Zenome platform user is engaged in many types of different interactions throughout the system. These interactions take place at different system levels, don’t interfere with each other and involve different patterns of interactions. Thus, they should be represented as distinct entities that have different roles.
The participants who provide resources for the operation of this network receive payments for it in Zenome tokens.
|Pre-sale start date||17 Oct 2017|
|Pre-sale end date||24 Oct 2017|
|Pre-sale token supply||353,173|
|ICO start date||03 Sep 2018|
|ICO end date||17 Sep 2018|
|ICO token supply||3,500,000|
|Soft cap||350,000 USD (fiat)|
|Hard cap size||1,150,000 USD (fiat)|
|Additional Token Emission||No|
Customer's friends have to sign up via link and customer receives 5% of ZNA from each of their transactions
10% - Zenome foundation
40% - R&D
Type of ratings
Rating Review and Analytics
$662,000 Of $1,150,000 (58%)
|Start ICO||03 Sep 2018|
|End ICO||17 Sep 2018|
|Price||1 ZNA = 1 USD|
Click vote if you want this project to be Post-ICO Rated.
The vote has been noted.